Topic
lupus
3 stories related to this topic, newest first.
manilatimes.netpolitics33 days ago
Cullinan Therapeutics Presents Phase 1 Data on CLN-978 at EULAR 2026 Congress
Cullinan Therapeutics reported initial clinical results from two Phase 1 trials of CLN-978, a CD19xCD3 T cell engager, in patients with systemic lupus erythematosus and rheumatoid arthritis. The data were presented June 6 at the European Alliance of Associations for Rheumatology…
Adrian McArdle, M.B, B.Ch., Kshemendra Senarath-Yapa, M.B.B.Chir., Graham G. Walmsley, B.S., Michael Hu, M.D., M.P.H., David A. Atashroo, M.D.,Ruth Tevlin, M.B., B.Ch.,Elizabeth Zielins, M.D.,Geoffrey C. Gurtner, M.D., Derrick C. Wan, M.D., and Michael T. Longaker, M.D., F.A.C.S. / Wikimedia (CC BY-SA 4.0)finance83 days ago
Nkarta Receives Approval for Outpatient Dosing in Lupus Nephritis Trial
Nkarta announced that regulators have approved a protocol change allowing outpatient dosing of its NKX019 therapy in lupus nephritis trials, reducing patient monitoring time to two hours. Following this update, Nkarta's stock price increased by approximately 13%.
Adrian McArdle, M.B, B.Ch., Kshemendra Senarath-Yapa, M.B.B.Chir., Graham G. Walmsley, B.S., Michael Hu, M.D., M.P.H., David A. Atashroo, M.D.,Ruth Tevlin, M.B., B.Ch.,Elizabeth Zielins, M.D.,Geoffrey C. Gurtner, M.D., Derrick C. Wan, M.D., and Michael T. Longaker, M.D., F.A.C.S. / Wikimedia (CC BY-SA 4.0)science91 days ago
Researchers Report B Cell Rebooting Success in Additional Autoimmune Diseases
A study has demonstrated the effectiveness of B cell rebooting in treating myasthenia gravis and other autoimmune conditions. The approach, previously tested in lupus and multiple sclerosis, involves depleting and resetting B cells. @EricTopol reported on the findings, highlighti…
ER